CAPTRUST FINANCIAL ADVISORS - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,008,595
+284.8%
26,403
+473.2%
0.00%
+300.0%
Q4 2022$262,082
+52.4%
4,606
+18.0%
0.00%0.0%
Q2 2022$172,000
+27.4%
3,902
+15.6%
0.00%0.0%
Q1 2022$135,000
+3.1%
3,374
+3.9%
0.00%0.0%
Q4 2021$131,000
+11.0%
3,247
+12.0%
0.00%0.0%
Q3 2021$118,000
+0.9%
2,898
+12.1%
0.00%0.0%
Q2 2021$117,000
+8.3%
2,585
-0.1%
0.00%0.0%
Q1 2021$108,000
+30.1%
2,588
+32.4%
0.00%0.0%
Q4 2020$83,000
+84.4%
1,955
+15.0%
0.00%0.0%
Q3 2020$45,000
-4.3%
1,7000.0%0.00%0.0%
Q2 2020$47,000
+80.8%
1,7000.0%0.00%0.0%
Q3 2019$26,000
-10.3%
1,7000.0%0.00%0.0%
Q2 2019$29,000
+7.4%
1,7000.0%0.00%0.0%
Q1 2019$27,000
+8.0%
1,7000.0%0.00%0.0%
Q4 2018$25,000
-19.4%
1,7000.0%0.00%0.0%
Q3 2018$31,0001,7000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders